This bill introduces several significant changes to the practice of pharmacy in New Hampshire. It authorizes licensed health care professionals to dispense up to a 30-day supply of noncontrolled oral anti-cancer medications, provided that a full-time licensed pharmacist is available for consultation and that dispensing adheres to relevant standards and laws. Additionally, the bill amends the display requirements for pharmacy licenses, allowing them to be readily retrievable rather than conspicuously displayed. It also permits licensed advanced pharmacy technicians to engage in remote processing, thereby expanding the roles of pharmacy staff.

Furthermore, the bill removes the requirement for a pharmacist's name or initials to be included on labels for controlled drugs, and it redefines the "practice of pharmacy" to encompass a broader range of patient care services. The authority of the board of pharmacy regarding collaborative pharmacy practice agreements is also reduced, and the bill clarifies the education and training standards for pharmacists administering medications outside of collaborative agreements. These changes aim to enhance the efficiency and effectiveness of pharmacy services while ensuring patient safety and compliance with regulations.

Statutes affected:
Introduced: 318:42, 318:28, 318:39, 318:15-, 318-B:13, 318:5-a, 318:16-a
SB504 text: 318:42, 318:28, 318:39, 318:15-d, 318-B:13, 318:5-a, 318:16-a